| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 9e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.001 |